Inventor
XUE-HAI LIANG
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes39%
A61KPreparations for medical, dental or toiletry purposes17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C07HSugars17%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture6%
C12YEnzymes6%
PatentTitleYear
12,595,482Linkage modified oligomeric compounds and uses thereof202612,234,447Modified compounds and uses thereof202512,030,910Compounds and methods for the modulation of proteins202411,629,348Linkage modified oligomeric compounds and uses thereof202311,492,617Compositions and methods for modulation of protein aggregation202211,332,733Modified compounds and uses thereof202211,149,264Modified compounds and uses thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to IONIS PHARMACEUTICALS INC (7)· patent assignee history
2021–2026Based in US· patent location history
2022Patents assigned to LONIS PHARMACEUTICALS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IONIS PHARMACEUTICALS INC | 7 | 2021–2026 |
| LONIS PHARMACEUTICALS INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2026 |